欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/V/0241/001
药品名称Zylexis
活性成分
    • parapoxvirus ovis 230.0 IFN/ml
剂型Suspension for injection
上市许可持有人Pfizer Limited Sandwich, Kent CT13 9NJ United Kingdom
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Denmark (DK)
      Zylexis
    • Belgium (BE)
    • Netherlands (NL)
      Zylexis
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
    • France (FR)
      ZYLEXIS
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Romania (RO)
    • Slovenia (SI)
      ZYLEXIS
许可日期2007/06/22
最近更新日期2015/01/15
药物ATC编码
    • QL03AX Other immunostimulants
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Full dossier - art 12.3 Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase